NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2024. All Rights Reserved.
Date: Wednesday, May 22, 2024 21:52

Release 2.150
Aquatet® 100% w/w Premix for Medicated Feeding Stuff
 
Species: Fish
Therapeutic indication: Medicinal feed additives: Antimicrobials and antimicrobials combination
Active ingredient: Oxytetracycline Hydrochloride
Product:Aquatet® 100% w/w Premix for Medicated Feeding Stuff
Product index: Aquatet
Fish - meat: 720 degree days
Incorporating:
Presentation
A fine yellow powder comprising 100% w/w oxytetracycline hydrochloride.
Uses
Use for the treatment and control of furunculosis due to Aeromonas salmonicida, and columnaris disease in Atlantic salmon, and furunculosis and enteric redmouth disease in Rainbow trout.
Dosage and administration
The product is given by oral administration at a rate of 75 mg per kg bodyweight of fish daily for initially 4 days. After the initial treatment, mortalities should be assessed and a further 4 day treatment course should be administered if necessary.
Aquatet is for administration only through the feed by mixing with manufactured feed prior to feeding. Feeding rates will vary according to water temperature and it may therefore be more convenient to medicate on the basis of a fixed rate e.g. 1% of bodyweight, with the extra daily feed requirement being met by unmedicated food. The following inclusion rates will provide the recommended dose:
Aquatet Powder inclusion rate:
Daily feed rate % bodyweight
per 5 kg
of food
per 25 kg
of food
per tonne
of food
½
75 g
375 g
15 kg
1
37.5 g
187.5 g
7.5 kg
2
18.75 g
93.75 g
3.75 kg
Weigh out appropriate amounts of fish pellets and product and mix well together in the dry state. As an aid to the adhesion of the product to the fish pellets, a small quantity of tepid gelatin solution or edible oil is then added to the food while mixing. Sufficient quantity should be mixed into the medicated food until it is slightly dampened.
Contra-indications, warnings, etc
Do not use in animals with known hypersensitivity to the active ingredient.
Do not administer together with growth promoters or other antibiotics.
Medicated feed should be used for the treatment period only.
It is essential to obtain consent from the local regional office of the Environment Agency or SEPA before using Aquatet.
Withdrawal period:
Animals must not be slaughtered for human consumption during treatment. Fish may be slaughtered for human consumption from 720° days after the last treatment.
Operator warnings:
If you know you are hypersensitive (allergic) to oxytetracycline, do not handle the product.
When handling the product, inhalation of the dust must be avoided by wearing a disposable half-mask respirator conforming to European Standard EN 149 (FFP2) or a non-disposable respirator to European Standard EN 140 with a filter to EN 143.
Avoid contact with skin and eyes. Gloves should be worn whilst handling this product. If contact with skin or eyes occurs, wash area immediately with copious amounts of fresh water. If irritation persists, seek medical attention.
Hands and exposed skin should be washed thoroughly after use.
Pharmaceutical precautions
Store in a dry place. Store in a tightly closed original container. Do not store above below 25°C. Protect from light.
Due to the hydroscopic nature of product, any open part used packs should be discarded and not resealed for later use. Protect from light. Medicated diet should be used for the treatment period only.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Keep out of the sight and reach of children.
For animal treatment only.
Legal category
Legal category: POM-V
Packaging quantities
Available in 1 kg plastic tubs, 2.5 kg buckets and 25 kg drums. Not all pack sizes may be marketed.
Further information
Aquatet may be used in brood stock.
Oxytetracycline has a wide safety margin. Furthermore, the product administered onto food in this manner cannot be expected to lead to overdose.
Marketing Authorisation Number
Vm 11003/4002
Significant changes